United States Certolizumab Pegol Market Report 2016

November 2016 | 103 pages | ID: U658AEC354CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Certolizumab Pegol

Revenue, means the sales value of Certolizumab Pegol

This report studies sales (consumption) of Certolizumab Pegol in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Sandoz
• Sanofi
• CASI Pharmaceuticals
• Delenex Therapeutics
• Novartis
• Delenex Therapeutics
• Ablynx
• Shanghai CP Guojian Pharmaceutical
• Zydus Cadila

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Certolizumab Pegol in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Certolizumab Pegol Market Report 2016

1 CERTOLIZUMAB PEGOL OVERVIEW

1.1 Product Overview and Scope of Certolizumab Pegol
1.2 Classification of Certolizumab Pegol
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Certolizumab Pegol
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Certolizumab Pegol (2011-2021)
  1.4.1 United States Certolizumab Pegol Sales and Growth Rate (2011-2021)
  1.4.2 United States Certolizumab Pegol Revenue and Growth Rate (2011-2021)

2 UNITED STATES CERTOLIZUMAB PEGOL COMPETITION BY MANUFACTURERS

2.1 United States Certolizumab Pegol Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Certolizumab Pegol Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Certolizumab Pegol Average Price by Manufactures (2015 and 2016)
2.4 Certolizumab Pegol Market Competitive Situation and Trends
  2.4.1 Certolizumab Pegol Market Concentration Rate
  2.4.2 Certolizumab Pegol Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CERTOLIZUMAB PEGOL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Certolizumab Pegol Sales and Market Share by Type (2011-2016)
3.2 United States Certolizumab Pegol Revenue and Market Share by Type (2011-2016)
3.3 United States Certolizumab Pegol Price by Type (2011-2016)
3.4 United States Certolizumab Pegol Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CERTOLIZUMAB PEGOL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Certolizumab Pegol Sales and Market Share by Application (2011-2016)
4.2 United States Certolizumab Pegol Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CERTOLIZUMAB PEGOL MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Certolizumab Pegol Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sandoz
  5.2.2 Certolizumab Pegol Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sandoz Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Certolizumab Pegol Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 CASI Pharmaceuticals
  5.4.2 Certolizumab Pegol Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 CASI Pharmaceuticals Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Delenex Therapeutics
  5.5.2 Certolizumab Pegol Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Delenex Therapeutics Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis
  5.6.2 Certolizumab Pegol Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Delenex Therapeutics
  5.7.2 Certolizumab Pegol Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Delenex Therapeutics Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Ablynx
  5.8.2 Certolizumab Pegol Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Ablynx Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Shanghai CP Guojian Pharmaceutical
  5.9.2 Certolizumab Pegol Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Shanghai CP Guojian Pharmaceutical Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Zydus Cadila
  5.10.2 Certolizumab Pegol Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Zydus Cadila Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 CERTOLIZUMAB PEGOL MANUFACTURING COST ANALYSIS

6.1 Certolizumab Pegol Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Certolizumab Pegol

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Certolizumab Pegol Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Certolizumab Pegol Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CERTOLIZUMAB PEGOL MARKET FORECAST (2016-2021)

10.1 United States Certolizumab Pegol Sales, Revenue Forecast (2016-2021)
10.2 United States Certolizumab Pegol Sales Forecast by Type (2016-2021)
10.3 United States Certolizumab Pegol Sales Forecast by Application (2016-2021)
10.4 Certolizumab Pegol Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Certolizumab Pegol
Table Classification of Certolizumab Pegol
Figure United States Sales Market Share of Certolizumab Pegol by Type in 2015
Table Application of Certolizumab Pegol
Figure United States Sales Market Share of Certolizumab Pegol by Application in 2015
Figure United States Certolizumab Pegol Sales and Growth Rate (2011-2021)
Figure United States Certolizumab Pegol Revenue and Growth Rate (2011-2021)
Table United States Certolizumab Pegol Sales of Key Manufacturers (2015 and 2016)
Table United States Certolizumab Pegol Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Certolizumab Pegol Sales Share by Manufacturers
Figure 2016 Certolizumab Pegol Sales Share by Manufacturers
Table United States Certolizumab Pegol Revenue by Manufacturers (2015 and 2016)
Table United States Certolizumab Pegol Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Certolizumab Pegol Revenue Share by Manufacturers
Table 2016 United States Certolizumab Pegol Revenue Share by Manufacturers
Table United States Market Certolizumab Pegol Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Certolizumab Pegol Average Price of Key Manufacturers in 2015
Figure Certolizumab Pegol Market Share of Top 3 Manufacturers
Figure Certolizumab Pegol Market Share of Top 5 Manufacturers
Table United States Certolizumab Pegol Sales by Type (2011-2016)
Table United States Certolizumab Pegol Sales Share by Type (2011-2016)
Figure United States Certolizumab Pegol Sales Market Share by Type in 2015
Table United States Certolizumab Pegol Revenue and Market Share by Type (2011-2016)
Table United States Certolizumab Pegol Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Certolizumab Pegol by Type (2011-2016)
Table United States Certolizumab Pegol Price by Type (2011-2016)
Figure United States Certolizumab Pegol Sales Growth Rate by Type (2011-2016)
Table United States Certolizumab Pegol Sales by Application (2011-2016)
Table United States Certolizumab Pegol Sales Market Share by Application (2011-2016)
Figure United States Certolizumab Pegol Sales Market Share by Application in 2015
Table United States Certolizumab Pegol Sales Growth Rate by Application (2011-2016)
Figure United States Certolizumab Pegol Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Certolizumab Pegol Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Certolizumab Pegol Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Certolizumab Pegol Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Certolizumab Pegol Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Certolizumab Pegol Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Certolizumab Pegol Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Certolizumab Pegol Sales Market Share (2011-2016)
Table Ablynx Basic Information List
Table Ablynx Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ablynx Certolizumab Pegol Sales Market Share (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Certolizumab Pegol Sales Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Certolizumab Pegol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila Certolizumab Pegol Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Certolizumab Pegol
Figure Manufacturing Process Analysis of Certolizumab Pegol
Figure Certolizumab Pegol Industrial Chain Analysis
Table Raw Materials Sources of Certolizumab Pegol Major Manufacturers in 2015
Table Major Buyers of Certolizumab Pegol
Table Distributors/Traders List
Figure United States Certolizumab Pegol Production and Growth Rate Forecast (2016-2021)
Figure United States Certolizumab Pegol Revenue and Growth Rate Forecast (2016-2021)
Table United States Certolizumab Pegol Production Forecast by Type (2016-2021)
Table United States Certolizumab Pegol Consumption Forecast by Application (2016-2021)